Literature DB >> 20412266

Does the E/e' index predict the maintenance of sinus rhythm after catheter ablation of atrial fibrillation?

Chen Li1, Xunshi Ding, Juqian Zhang, Can Zhou, Yu Chen, Li Rao.   

Abstract

INTRODUCTION: The role of left ventricular (LV) diastolic dysfunction in recurrent atrial fibrillation (AF) after catheter ablation remains unknown. We investigated LV diastolic function using the ratio of early transmitral flow velocity (E) to early diastolic mitral annular velocity (e') and evaluated its predictive value for AF recurrence.
METHODS: One hundred three AF patients underwent transthoracic echocardiography before ablation and during 3 months of follow-up. Clinical and echocardiographic parameters of patients with maintained sinus rhythm were compared with those with recurrent AF.
RESULTS: Of 103 patients, 26 had recurrent AF during follow-up. The E/e' index was the best independent predictor of AF recurrence in a multivariate logistic regression model. A cutoff value of 11.2 for the E/e' measured before ablation was associated with a sensitivity of 80.8% and specificity of 81.8% (area under ROC curve, 0.840; 95% CI, 0.754-0.926) for AF recurrence. E/e' measured in sinus rhythm after ablation had an even better predictive power (area under ROC curve, 0.917; 95% CI, 0.850-0.983).
CONCLUSION: LV diastolic function was closely associated with AF recurrence after catheter ablation. The E/e' index can be used as an incremental predictor for AF recurrence after catheter ablation.

Entities:  

Mesh:

Year:  2010        PMID: 20412266     DOI: 10.1111/j.1540-8175.2009.01123.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  8 in total

Review 1.  Clinical Relevance of the Spectral Tissue Doppler E/e' Ratio in the Management of Patients with Atrial Fibrillation: a Comprehensive Review of the Literature.

Authors:  Stephane Arques
Journal:  J Atr Fibrillation       Date:  2018-08-31

Review 2.  The Role of Echocardiography as a Predictor of the Incidence and Progression of Atrial Fibrillation.

Authors:  Rui Providência; Sérgio Barra; Luís Paiva
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 3.  Echocardiography In the Prediction of Atrial Fibrillation Recurrence: A Review.

Authors:  Maria Caputo; Sergio Mondillo
Journal:  J Atr Fibrillation       Date:  2012-08-20

4.  Increased left atrial size is associated with higher atrial fibrillation recurrence in patients treated with antiarrhythmic medications.

Authors:  Saarang Mulukutla; Andrew D Althouse; Sandeep K Jain; Samir Saba
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

Review 5.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26

6.  Effects of two kinds of radio frequency ablations on morphology and function of left atrium in patients with atrial fibrillation.

Authors:  Gang Lin; Xiang-Jun Yang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation.

Authors:  Judit Simon; Mohammed El Mahdiui; Jeff M Smit; Lili Száraz; Alexander R van Rosendael; Szilvia Herczeg; Emese Zsarnóczay; Anikó Ilona Nagy; Márton Kolossváry; Bálint Szilveszter; Nándor Szegedi; Klaudia Vivien Nagy; Tamás Tahin; László Gellér; Rob J van der Geest; Jeroen J Bax; Pál Maurovich-Horvat; Béla Merkely
Journal:  Clin Cardiol       Date:  2021-11-19       Impact factor: 2.882

8.  Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation.

Authors:  Gang Lin; Hui-He Lu; Yi Shen; Jian-Fei Huang; Lin-Sheng Shi; Yi-Nan Guo
Journal:  Exp Ther Med       Date:  2013-06-14       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.